Clinical trial
Assessment of Safety and Efficacy of Poteligeo Inj. 20 mg (Mogamulizumab) Through Use-result Surveillance
NCT07132567 is registered in ClinicalTrials.gov with Kyowa Kirin Co., Ltd. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Assessment of Safety and Efficacy of Poteligeo Inj. 20 mg (Mogamulizumab) Through Use-result Surveillance
- Lead sponsor
- Kyowa Kirin Co., Ltd.
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- May 2, 2025
- Completion date
- November 30, 2028
- Enrollment
- 15 (estimated)
- Sites
- 6
Conditions
As the registry lists them; a condition with its own page is linked.